-
Cutting Cancer’s EngineRenewed interest in research about metabolism, the process cells use to fuel their growth, could lead to new types of cancer treatments.
by Stephen Ornes
-
Missing the MarkOnly one-third of new cancer therapies or drug combinations tested in phase III clinical trials prove to be better than the standard of care. Researchers explain why and how they are aiming to improve the odds.
by Sue Rochman
-
Healthy Habits
Going With the GrainA fiber-rich diet can reduce cancer risk.
by Alanna Kennedy-Gorman
-
Q&A
Age Is More Than a NumberGeriatric oncologist Harvey Jay Cohen shines a spotlight on older people with cancer.
by Jocelyn Selim
-
Forward Look
Bridging the DistanceQ&A with medical oncologist Ana María López, medical director of the telemedicine program at the University of Arizona Cancer Center in Tucson.
by Sue Rochman
-
Forward Look
Treading Carefully With Medical ScansTo reduce your long-term cancer risk, make sure the tests are justified.
by Ingfei Chen
-
Forward Look
A Trojan Horse to Fight CancerAn experimental treatment shows the potential of a new family of targeted drugs.
by Stephen Ornes
-
Forward Look
Common-Sense ScreeningSigmoidoscopy may be a good option for colorectal cancer screening.
by Sue Rochman
-
Forward Look
Task Force Says “No” to PSA for Prostate Cancer ScreeningExpert panel's recommendation spurs debate.
by Stephen Ornes
-
A Genetic LegacyDoctors now know more than ever about the inherited cancer-related mutations that can link generations of family members. But with the new knowledge from scientific advances and DNA testing come new questions for patients.
by Sue Rochman
Tailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
